Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Brian Dorsey Insider Profile
4 Followers
Brian Dorsey, Former SVP, Chief Dev Officer at Seelos Therapeutics, holds 115.89K shares in Seelos Therapeutics (Ticker: SEEL), holds ― shares in ARS Pharmaceuticals (Ticker: SPRY), holds 87.43K shares in Pernix Therapeutics (Ticker: PTXTQ).
Brian Dorsey has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Brian Dorsey holds in companies
Most Profitable Insider Trade
The most profitable trade made by Brian Dorsey
Brian Dorsey's Trading History
Seelos Therapeutics
Sep 04, 2018
Former SVP, Chief Dev Officer
Uninformative Sell
14.26K
$33.49K
ARS Pharmaceuticals
―
COO
―
―
Pernix Therapeutics
Oct 10, 2014
―
Uninformative Buy
―
$2.45K
Somaxon Pharmaceuticals
―
―
―
―
List of latest transactions for each holding click on a transaction to see Brian Dorsey's performance on stock
You May Also Like
Brian Dorsey insider profile FAQ
What is the percentage of profitable transactions made by Brian Dorsey?
The percentage of profitable transactions made by Brian Dorsey is ―.
What is the average return per transaction made by Brian Dorsey?
The average return per transaction made by Brian Dorsey is ―.
What stocks does Brian Dorsey hold?
Brian Dorsey holds: SEEL, SPRY, PTXTQ, SOMX stocks.
What was Brian Dorsey’s latest transaction?
Brian Dorsey latest transaction was an Uninformative Sell of $14.26K.
What was Brian Dorsey's most profitable transaction?
Brian Dorsey’s most profitable transaction was an Informative Buy of SEEL stock on December 30, 2014. The return on the trade was 3.20%.
What is Brian Dorsey's role in Seelos Therapeutics?
Brian Dorsey's role in Seelos Therapeutics is Former SVP, Chief Dev Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.